Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, shared a post on X:
“TargetCancer has a dedicated National Molecular Tumor Board for rare cancers.
Experts from Harvard, MD Anderson, MCW, City of Hope, John Hopkins, Foundation Medicine, TargetCancer Foundation. And more gather weekly to help patients either be rare cancers.”
Other articles featuring Razelle Kurzrock on OncoDaily.